Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor

被引:57
作者
Vine, MF
Ness, RB
Calingaert, B
Schildkraut, JM
Berchuck, A
机构
[1] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA
[3] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA
关键词
ovarian cancer; symptoms; invasive; borderline; diagnosis;
D O I
10.1006/gyno.2001.6411
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The objective was to describe and compare types and duration of symptoms among women with invasive versus borderline ovarian tumors. Methods. Cases were women, ages 20-69 years, diagnosed with invasive (616) and borderline (151) epithelial ovarian tumors from 1994 to 1998, Symptoms were obtained using a standardized in-person interview. Differences in types and duration of symptoms, time to diagnosis after consulting a physician, and primary reason for diagnosis by invasive[borderline status and histologic type were determined using bivariate and regression analyses controlling for age. Results, Borderline and invasive cases reported similar types of symptoms. However, borderline cases were twice as likely to report not having had symptoms as invasive cases (16 vs 8%, P = 0.005). Prediagnostic symptom duration was longer among borderline versus invasive cases (median: 6 vs 4 months, P < 0.001). The median time from first consultation with a physician to diagnosis (1 month) did not differ by invasive[borderline status. Borderline cases were twice as likely to be diagnosed through routine examination as invasive cases (28 vs 16%, P = 0.001). Invasive cases were more likely to be diagnosed because of symptoms (62 vs 48%, P = 0.002). Conclusions. Because most (90%) women with ovarian tumors have symptoms and median symptom duration is 4 months, greater awareness of symptoms by women and physicians is needed for the earlier detection of ovarian tumors. The lesser likelihood of being detected by routine examination and the shorter symptom duration for invasive versus borderline cases underscores the need for effective screening and preventive strategies. (C) 2001 Academic Press.
引用
收藏
页码:466 / 471
页数:6
相关论文
共 27 条
[1]  
*AM CANC SOC, 1999, CANC FACTS FIG 1999
[2]  
BELL DA, 1994, CANCER, V73, P1859, DOI 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO
[3]  
2-L
[4]   Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer [J].
Eltabbakh, GH ;
Natarajan, N ;
Piver, MS ;
Mettlin, CJ .
GYNECOLOGIC ONCOLOGY, 1999, 74 (01) :103-107
[5]   Clinical picture of women with early stage ovarian cancer [J].
Eltabbakh, GH ;
Yadev, PR ;
Morgan, A .
GYNECOLOGIC ONCOLOGY, 1999, 75 (03) :476-479
[6]   Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors [J].
Engelen, MJA ;
de Bruijn, HWA ;
Hollema, H ;
ten Koor, KA ;
Willemse, PHB ;
Aalders, JG ;
van der Zee, AGJ .
GYNECOLOGIC ONCOLOGY, 2000, 78 (01) :16-20
[7]   SYMPTOMATOLOGY OF OVARIAN-CANCER [J].
FLAM, F ;
EINHORN, N ;
SJOVALL, K .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1988, 27 (01) :53-57
[8]  
Goff BA, 2000, CANCER, V89, P2068, DOI 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO
[9]  
2-Z
[10]   CA 125 measurement and ultrasonography in borderline tumors of the ovary [J].
Gotlieb, WH ;
Soriano, D ;
Achiron, R ;
Zalel, Y ;
Davidson, B ;
Kopolovic, J ;
Novikov, I ;
Ben-Baruch, G .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (03) :541-546